SanofiSNYNF
13F holders, Q4 2024 (December 31)3holders +1
0new positions
0sold out
$97.00avg. 13F price*
At the end of Q4 2024, 3 institutions reported holding Sanofi (SNYNF) in their 13F filings, up 1 from Q3 2024. 0 opened new positions and 0 sold out. The largest holders were Generali Investments CEE, investicni spolecnost, a.s. ($3.1M), GAMMA Investing LLC ($26K) and Cyrus J. Lawrence, LLC ($14K).
- Company
- Sanofi
- CUSIP
- F5548N101
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2024 → Q4 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 0 | $0 |
All 13F filers, Q3 2024 → Q4 2024: 212 shares bought, net +212 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 3 holders
| Generali Investments CEE, investicni spolecnost, a.s. | 0.32% | — | 31,673 | $3.1M |
| GAMMA Investing LLC | 0.00% | Add +365.5% | 270 | $26K |
| Cyrus J. Lawrence, LLC | 0.00% | No change | 150 | $14K |
"% of holder's portfolio" is SNYNF's weight in each manager's 13F, not the share of Sanofi the manager owns.